Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background/objectives: Obesity is a major cause of metabolic disorders; to prevent obesity, research is ongoing to develop natural and safe ingredients with few adverse effects. In this study, we determined the anti-obesity effects of root extract (KWFD-H01) in 3T3-L1 adipocytes and Sprague-Dawley (SD) rats.

Materials/methods: The anti-obesity effects of KWFD-H01in 3T3-L1 adipocytes and SD rats were examined using various assays, including Oil Red O staining, gene expression analyses, protein expression analyses, and blood biochemical analyses.

Results: KWFD-H01 reduced intracellular lipid accumulation and inhibited the mRNA expression of peroxisome proliferator-activated receptor γ (PPARγ), cytidine-cytidine-adenosine-adenosine-thymidine (CCAAT)/enhancer binding proteins (C/EBPα), sterol regulatory element-binding transcription factor 1 (SREBP-1c), acetyl-CoA carboxylase (ACC), and fatty acid synthase (FAS) in 3T3-L1 cells. KWFD-H01 also reduced body weight, weight gain, and the levels of triglycerides, total and LDL-cholesterol, glucose, and leptin, while increasing high-density lipoprotein-cholesterol and adiponectin in SD rats. PPARγ, C/EBPα, SREBP-1c, ACC, and FAS protein expression was inhibited in the epididymal fat of SD rats.

Conclusion: Overall, these results confirm the anti-obesity effects of KWFD-H01 in 3T3-L1 adipocytes and SD rats, indicating their potential as baseline data for developing functional health foods or pharmaceuticals to control obesity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10995778PMC
http://dx.doi.org/10.4162/nrp.2024.18.2.180DOI Listing

Publication Analysis

Top Keywords

3t3-l1 adipocytes
16
anti-obesity effects
12
effects root
8
root extract
8
kwfd-h01 3t3-l1
8
adipocytes rats
8
expression analyses
8
protein expression
8
kwfd-h01 reduced
8
effects
5

Similar Publications

Fatty acid-binding protein 4 (FABP4) is a cytosolic lipid chaperone predominantly expressed in adipocytes. It has been shown that targets adipose tissues and resides in adipocytes. However, how manipulates adipocytes to redirect nutrients for its benefit remains unknown.

View Article and Find Full Text PDF

KU4 inhibits adipocyte senescence in aged mice through necdin regulation of p53 activity.

Aging (Albany NY)

September 2025

Department of Biological Sciences, College of Natural Sciences, Chonnam National University, Buk-gu, Gwangju 61186, Republic of Korea.

Previously, we reported that KU4 (LKU4) ameliorates diet-induced metabolic disorders by regulating adipose tissue (AT) physiology. Since metabolic disorders and age-related pathological conditions mutually exacerbate each other, this study hypothesizes that LKU4 may protect against adipose senescence during aging. Thus, this study demonstrates that LKU4 administration suppresses age-related metabolic dysfunction and aging phenotypes in AT of 24-month-old mice.

View Article and Find Full Text PDF

The antiadipogenic effect of the pentacyclic triterpenoid isoarborinol is mediated by LKB1-AMPK activation.

PLoS One

September 2025

Instituto Politécnico Nacional, Escuela Nacional de Medicina y Homeopatía, Laboratorio de Biomedicina Molecular 2, México City, México.

Obesity and overweight are two highly prevalent conditions worldwide, which can lead to death or produce chronic and degenerative diseases. The search for alternative therapies to control these morbidities can involve the study of metabolites obtained from plants. Particularly, pentacyclic triterpenes produce an antiadipogenic effect by affecting the expression of master regulators of adipogenesis and their signaling pathways, including LKB1-AMPK pathway.

View Article and Find Full Text PDF

Anti-Obesity Effects of Extracts via the AMPK Signaling Pathway in 3T3-L1 Adipocytes.

Prev Nutr Food Sci

August 2025

Division of Natural Product Research, Korea Prime Pharmacy Co., Ltd., Gyeonggi 16229, Korea.

Obesity is a major public health concern because of its association with metabolic disorders (e.g., type 2 diabetes mellitus) and cardiovascular diseases.

View Article and Find Full Text PDF

Objective: This study investigates the regulatory role of p53 on Lgals3 expression and its impact on preadipocyte differentiation, fatty acid synthesis, and oxidation in obesity.

Methods: Bioinformatics analysis of six obesity-related microarray datasets and single-cell RNA sequencing (scRNA-seq) data identified Lgals3 as a key obesity-associated gene. A high-fat diet (HF) mouse model was established to evaluate obesity-related phenotypes, including body weight, hepatic Lgals3 expression, adipose tissue pathology, blood lipid profiles, and glucose tolerance.

View Article and Find Full Text PDF